{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:04:33Z","timestamp":1783094673810,"version":"3.54.6"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lianyungang Science and Technology Bureau of Social Development Key R&D Projects","award":["SF2319"],"award-info":[{"award-number":["SF2319"]}]},{"name":"Youth Science and Technology Project of Lianyungang Municipal Health Commission","award":["QN202310"],"award-info":[{"award-number":["QN202310"]}]},{"name":"Medical scientific research project of the Suzhou clinical Medical Center for mood disorders","award":["No.Szlcyxzx202109"],"award-info":[{"award-number":["No.Szlcyxzx202109"]}]},{"name":"Suzhou Key Laboratory","award":["SZS2024016"],"award-info":[{"award-number":["SZS2024016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07560-2","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:28:21Z","timestamp":1763404101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlations of oxidative stress markers with niacin sensitivity in male patients with chronic schizophrenia"],"prefix":"10.1186","volume":"25","author":[{"given":"Man","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"7560_CR1","doi-asserted-by":"publisher","first-page":"771144","DOI":"10.3389\/fpsyt.2021.771144","volume":"12","author":"SH Ansarey","year":"2021","unstructured":"Ansarey SH. Inflammation and jnk\u2019s role in niacin-GPR109A diminished flushed effect in microglial and neuronal cells with relevance to schizophrenia. Front Psychiatry. 2021;12:771144.","journal-title":"Front Psychiatry"},{"key":"7560_CR2","doi-asserted-by":"publisher","first-page":"703452","DOI":"10.3389\/fpsyt.2021.703452","volume":"12","author":"AJ Murray","year":"2021","unstructured":"Murray AJ, Rogers JC, Katshu MZUH, Liddle PF, Upthegrove R. Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders. Front Psychiatry. 2021;12:703452.","journal-title":"Front Psychiatry"},{"key":"7560_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.plefa.2017.06.014","volume":"136","author":"E Messamore","year":"2017","unstructured":"Messamore E. The niacin response biomarker as a schizophrenia endophenotype: a status update. Prostaglandins Leukot Essent Fat Acids. 2017;136:95\u20137.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"7560_CR4","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.plefa.2020.102084","volume":"155","author":"S Nadalin","year":"2020","unstructured":"Nadalin S, Jonovska S, \u0160endula Jengic V, Buretic-Tomljanovic A. An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia. Prostaglandins Leukot Essent Fat Acids. 2020;155:102084.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"7560_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia\u2013a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64:361\u20138.","journal-title":"Biol Psychiatry"},{"key":"7560_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O\u2019Neil A, et al. Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev. 2014;45:46\u201362.","journal-title":"Neurosci Biobehav Rev"},{"key":"7560_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41537-024-00468-y","volume":"10","author":"H Yang","year":"2024","unstructured":"Yang H, Sun W, Yang M, Li J, Zhang J, Zhang X. Variations to plasma H2O2 levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: correlations with psychopathology. Schizophrenia (Heidelb). 2024;10:45.","journal-title":"Schizophrenia (Heidelb)"},{"key":"7560_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","volume":"78","author":"HG Bernstein","year":"2005","unstructured":"Bernstein HG, Bogerts B, Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res. 2005;78:69\u201386.","journal-title":"Schizophr Res"},{"key":"7560_CR9","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.2174\/1381612825666190115121018","volume":"24","author":"R Wadhwa","year":"2018","unstructured":"Wadhwa R, Gupta R, Maurya PK. Oxidative stress and accelerated aging in neurodegenerative and neuropsychiatric disorder. Curr Pharm Des. 2018;24:4711\u201325.","journal-title":"Curr Pharm Des"},{"key":"7560_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cbi.2014.10.016","volume":"224","author":"VI Lushchak","year":"2014","unstructured":"Lushchak VI. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact. 2014;224:164\u201375.","journal-title":"Chem Biol Interact"},{"key":"7560_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.euroneuro.2020.04.002","volume":"35","author":"A Esshili","year":"2020","unstructured":"Esshili A, Manitz MP, Freund N, Juckel G. Induction of inducible nitric oxide synthase expression in activated microglia and astrocytes following pre- and postnatal immune challenge in an animal model of schizophrenia. Eur Neuropsychopharmacol. 2020;35:100\u201310.","journal-title":"Eur Neuropsychopharmacol"},{"key":"7560_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fphys.2015.00139","volume":"6","author":"RF Nasyrova","year":"2015","unstructured":"Nasyrova RF, Ivashchenko DV, Ivanov MV, Neznanov NG. Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. Front Physiol. 2015;6:139.","journal-title":"Front Physiol"},{"key":"7560_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuroscience.2015.05.018","volume":"300","author":"GZ R\u00e9us","year":"2015","unstructured":"R\u00e9us GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141\u201354.","journal-title":"Neuroscience"},{"key":"7560_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.schres.2025.04.003","volume":"280","author":"CW Chiu","year":"2025","unstructured":"Chiu CW, Chen BY, Lin JJ, Tseng HH, Huang CC, Wang TY, et al. Developing a risk assessment model for treatment-resistant schizophrenia: the role of niacin receptor GPR109A and prostaglandin receptors DP1, EP2, and EP4 in the niacin-induced Flushing pathway. Schizophr Res. 2025;280:30\u20138.","journal-title":"Schizophr Res"},{"key":"7560_CR15","doi-asserted-by":"publisher","first-page":"8881770","DOI":"10.1155\/2021\/8881770","volume":"2021","author":"EA Ermakov","year":"2021","unstructured":"Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives. Oxid Med Cell Longev. 2021;2021:8881770.","journal-title":"Oxid Med Cell Longev"},{"key":"7560_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11571-019-09530-3","volume":"13","author":"T Xie","year":"2019","unstructured":"Xie T, Li Q, Luo X, Tian L, Wang Z, Tan S, et al. Plasma total antioxidant status and cognitive impairments in first-episode drug-na\u00efve patients with schizophrenia. Cogn Neurodyn. 2019;13:357\u201365.","journal-title":"Cogn Neurodyn"},{"key":"7560_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0920-9964(03)00070-7","volume":"68","author":"J Ramirez","year":"2004","unstructured":"Ramirez J, Garnica R, Boll MC, Montes S, Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophr Res. 2004;68:357\u201361.","journal-title":"Schizophr Res"},{"key":"7560_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.schres.2008.06.005","volume":"104","author":"BH Lee","year":"2008","unstructured":"Lee BH, Kim YK. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls. Schizophrenia Res. 2008;104:36\u201343.","journal-title":"Schizophrenia Res"},{"key":"7560_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1515\/CCLM.2010.014","volume":"48","author":"VV Djordjevi\u0107","year":"2010","unstructured":"Djordjevi\u0107 VV, Stojanovi\u0107 I, Stankovi\u0107-Ferlez D, Risti\u0107 T, Lazarevi\u0107 D, Cosi\u0107 V, et al. Plasma nitrite\/nitrate concentrations in patients with schizophrenia. Clin Chem Lab Med. 2010;48:89\u201394.","journal-title":"Clin Chem Lab Med"},{"key":"7560_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1517\/14656566.2012.713346","volume":"13","author":"G Minutolo","year":"2012","unstructured":"Minutolo G, Petralia A, Dipasquale S, Aguglia E. Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment. Expert Opin Pharmacother. 2012;13:1989\u201397.","journal-title":"Expert Opin Pharmacother"},{"key":"7560_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.05.005","volume":"78","author":"S Mitra","year":"2017","unstructured":"Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017;78:1\u201311.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7560_CR22","first-page":"e68231","volume":"16","author":"M Elnoor","year":"2024","unstructured":"Elnoor M, Bokhari SA, Singh M, Mohamed IA. Effectiveness of vitamin E in treatment of antipsychotic-induced tardive dyskinesia and extrapyramidal symptoms: a case report. Cureus. 2024;16:e68231.","journal-title":"Cureus"},{"key":"7560_CR23","first-page":"CD000209","volume":"1","author":"K Soares-Weiser","year":"2018","unstructured":"Soares-Weiser K, Maayan N, Bergman H. Vitamin E for antipsychotic-induced tardive dyskinesia. Cochrane Database Sys Rev. 2018;1:CD000209.","journal-title":"Cochrane Database Sys Rev"},{"key":"7560_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41537-025-00555-8","volume":"11","author":"Z Peng","year":"2025","unstructured":"Peng Z, Jia Q, Mao J, Jiang S, Ma Q, Luo X, et al. The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation. Schizophrenia (Heidelb). 2025;11:4.","journal-title":"Schizophrenia (Heidelb)"},{"key":"7560_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jpsychires.2020.09.003","volume":"131","author":"L Mu","year":"2020","unstructured":"Mu L, Liang J, Wang H, Chen D, Xiu M, Zhang XY. Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia. J Psychiatr Res. 2020;131:194\u2013202.","journal-title":"J Psychiatr Res"},{"key":"7560_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajp.2015.07.016","volume":"18","author":"TL da Silva","year":"2015","unstructured":"da Silva TL, Ravindran AV. Contribution of sex hormones to gender differences in schizophrenia: a review. Asian J Psychiatry. 2015;18:2\u201314.","journal-title":"Asian J Psychiatry"},{"key":"7560_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376.","journal-title":"Schizophr Bull"},{"key":"7560_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.psychres.2005.10.010","volume":"143","author":"L Bosveld-van Haandel","year":"2006","unstructured":"Bosveld-van Haandel L, Knegtering R, Kluiter H, van den Bosch RJ. Niacin skin Flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Res. 2006;143:303\u20136.","journal-title":"Psychiatry Res"},{"key":"7560_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/schbul\/sbx150","volume":"44","author":"L Sun","year":"2017","unstructured":"Sun L, Yang X, Jiang J, Hu X, Qing Y, Wang D, et al. Identification of the niacin-blunted subgroup of schizophrenia patients from mood disorders and healthy individuals in Chinese population. Schizophr Bull. 2017;44:896\u2013907.","journal-title":"Schizophr Bull"},{"key":"7560_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2021.02.009","volume":"230","author":"DD Wang","year":"2021","unstructured":"Wang DD, Hu XW, Jiang J, Sun LY, Qing Y, Yang XH, et al. Attenuated and delayed niacin skin Flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker. Schizophr Res. 2021;230:53\u201360.","journal-title":"Schizophr Res"},{"key":"7560_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0920-9964(01)00388-7","volume":"58","author":"G Xing","year":"2002","unstructured":"Xing G, Chavko M, Zhang LX, Yang S, Post RM. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res. 2002;58:21\u201330.","journal-title":"Schizophr Res"},{"key":"7560_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbr.2013.08.003","volume":"256","author":"JC Walton","year":"2013","unstructured":"Walton JC, Selvakumar B, Weil ZM, Snyder SH, Nelson RJ. Neuronal nitric oxide synthase and NADPH oxidase interact to affect cognitive, affective, and social behaviors in mice. Behav Brain Res. 2013;256:320\u20137.","journal-title":"Behav Brain Res"},{"key":"7560_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1176\/appi.ajp.2008.08081266","volume":"166","author":"NS Wratten","year":"2009","unstructured":"Wratten NS, Memoli H, Huang Y, Dulencin AM, Matteson PG, Cornacchia MA, et al. Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. Am J Psychiatry. 2009;166:434.","journal-title":"Am J Psychiatry"},{"key":"7560_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1017\/S1461145708008924","volume":"11","author":"W Tang","year":"2008","unstructured":"Tang W, Huang K, Tang R, Zhou G, Fang C, Zhang J, et al. Evidence for association between the 5\u2019 flank of the NOS1 gene and schizophrenia in the Chinese population. Int J Neuropsychopharmacol. 2008;11:1063\u201371.","journal-title":"Int J Neuropsychopharmacol"},{"key":"7560_CR35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.psychres.2016.10.015","volume":"246","author":"YJ Yang","year":"2016","unstructured":"Yang YJ, Xiong JW, Zhao Y, Zhan JQ, Chen HB, Yan K, et al. Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia. Psychiatry Res. 2016;246:480\u20134.","journal-title":"Psychiatry Res"},{"key":"7560_CR36","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.12669\/pjms.38.7.5326","volume":"38","author":"S Peng","year":"2022","unstructured":"Peng S, Liang C, Deng S, Fu Y. Study on the clinical correlation between the expression of serum TNF-\u03b1 and iNOS as well as cognitive impairment and disease burden in patients with schizophrenia. Pak J Med Sci. 2022;38:1838\u201343.","journal-title":"Pak J Med Sci"},{"key":"7560_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neubiorev.2014.06.002","volume":"45","author":"M Ghasemi","year":"2014","unstructured":"Ghasemi M, Fatemi A. Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases. Neurosci Biobehav Rev. 2014;45:168\u201382.","journal-title":"Neurosci Biobehav Rev"},{"key":"7560_CR38","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/ijms21051604","volume":"21","author":"RF Nasyrova","year":"2020","unstructured":"Nasyrova RF, Moskaleva PV, Vaiman EE, Shnayder NA, Blatt NL, Rizvanov AA. Genetic factors of nitric oxide\u2019s system in psychoneurologic disorders. Int J Mol Sci. 2020;21:1604.","journal-title":"Int J Mol Sci"},{"key":"7560_CR39","first-page":"278","volume":"43","author":"P Buosi","year":"2022","unstructured":"Buosi P, Borghi FA, Lopes AM, Facincani IDS, Fernandes-Ferreira R, Oliveira-Brancati CIF, et al. Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients. Trends Psychiatry Psychother. 2022;43:278\u201385.","journal-title":"Trends Psychiatry Psychother"},{"key":"7560_CR40","doi-asserted-by":"publisher","first-page":"896694","DOI":"10.3389\/fpsyt.2022.896694","volume":"13","author":"M Yang","year":"2022","unstructured":"Yang M, Li J, Yang H, Yan L, Liu D, Zhu L, et al. Cognitive impairment and psychopathology are related to plasma oxidative stress in long term hospitalized patients with chronic schizophrenia. Front Psychiatry. 2022;13:896694.","journal-title":"Front Psychiatry"},{"key":"7560_CR41","doi-asserted-by":"publisher","first-page":"11119","DOI":"10.3390\/ijms252011119","volume":"25","author":"B Kramar","year":"2024","unstructured":"Kramar B, Pirc Marolt T, Yilmaz Goler AM, \u0160uput D, Milisav I, Monsalve M, et al. Aripiprazole, but not olanzapine, alters the response to oxidative stress in Fao cells by reducing the activation of mitogen-activated protein kinases (MAPKs) and promoting cell survival. Int J Mol Sci. 2024;25:11119.","journal-title":"Int J Mol Sci"},{"key":"7560_CR42","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1124\/pr.120.019240","volume":"72","author":"V Kapil","year":"2020","unstructured":"Kapil V, Khambata RS, Jones DA, Rathod K, Primus C, Massimo G, et al. The noncanonical pathway for in vivo nitric oxide generation: the nitrate-nitrite-nitric oxide pathway. Pharmacol Rev. 2020;72:692\u2013766.","journal-title":"Pharmacol Rev"},{"key":"7560_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0006-8993(99)01444-4","volume":"834","author":"D Blum-Degen","year":"1999","unstructured":"Blum-Degen D, Heinemann T, Lan J, Pedersen V, Leblhuber F, Paulus W, et al. Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing. Brain Res. 1999;834:128\u201335.","journal-title":"Brain Res"},{"key":"7560_CR44","doi-asserted-by":"publisher","first-page":"1382878","DOI":"10.1155\/2022\/1382878","volume":"2022","author":"B Nasir","year":"2022","unstructured":"Nasir B, Khan AU, Baig MW, Althobaiti YS, Faheem M, Haq IU. Datura stramonium leaf extract exhibits anti-inflammatory activity in CCL4-induced hepatic injury model by modulating oxidative stress markers and iNOS\/Nrf2 expression. Biomed Res Int. 2022;2022:1382878.","journal-title":"Biomed Res Int"},{"key":"7560_CR45","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2174\/138161207780831275","volume":"13","author":"B Braam","year":"2007","unstructured":"Braam B, Verhaar MC. Understanding eNOS for Pharmacological modulation of endothelial function: a translational view. Curr Pharm Des. 2007;13:1727\u201340.","journal-title":"Curr Pharm Des"},{"key":"7560_CR46","doi-asserted-by":"publisher","first-page":"113304","DOI":"10.1016\/j.bbr.2021.113304","volume":"409","author":"JC Morales-Medina","year":"2021","unstructured":"Morales-Medina JC, Aguilar-Alonso P, Di Cerbo A, Iannitti T, Flores G. New insights on nitric oxide: focus on animal models of schizophrenia. Behav Brain Res. 2021;409:113304.","journal-title":"Behav Brain Res"},{"key":"7560_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","volume":"151","author":"BM Ribeiro","year":"2013","unstructured":"Ribeiro BM, do Carmo MR, Freire RS, Rocha NF, Borella VC, de Menezes AT, et al. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. Schizophr Res. 2013;151:12\u20139.","journal-title":"Schizophr Res"},{"key":"7560_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1017\/neu.2019.14","volume":"31","author":"DK Solberg","year":"2019","unstructured":"Solberg DK, Refsum H, Andreassen OA, Bentsen H. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Acta Neuropsychiatr. 2019;31:202\u201312.","journal-title":"Acta Neuropsychiatr"},{"key":"7560_CR49","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.3390\/jcm10184156","volume":"10","author":"D Juchnowicz","year":"2021","unstructured":"Juchnowicz D, Dzikowski M, Rog J, Waszkiewicz N, Karakula KH, Zalewska A, et al. Pro\/Antioxidant state as a potential biomarker of schizophrenia. J Clin Med. 2021;10:4156.","journal-title":"J Clin Med"},{"key":"7560_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/112_2021_61","volume":"180","author":"R Saini","year":"2021","unstructured":"Saini R, Azam Z, Sapra L, Srivastava RK. Neuronal nitric oxide synthase (nNOS) in neutrophils: an insight. Rev Physiol Biochem Pharmacol. 2021;180:49\u201383.","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"7560_CR51","doi-asserted-by":"publisher","first-page":"100783","DOI":"10.1016\/j.yfrne.2019.100783","volume":"55","author":"LS Kalinichenko","year":"2019","unstructured":"Kalinichenko LS, Kornhuber J, M\u00fcller CP. Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders. Front Neuroendocrinol. 2019;55:100783.","journal-title":"Front Neuroendocrinol"},{"key":"7560_CR52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","volume":"122","author":"E Messamore","year":"2010","unstructured":"Messamore E, Hoffman WF, Yao JK. Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res. 2010;122:248\u201356.","journal-title":"Schizophr Res"},{"key":"7560_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jnutbio.2016.09.008","volume":"39","author":"S Montserrat-de la Paz","year":"2017","unstructured":"Montserrat-de la Paz S, Naranjo MC, Lopez S, Abia R, Muriana FJG, Bermudez B. Niacin and its metabolites as master regulators of macrophage activation. J Nutr Biochem. 2017;39:40\u20137.","journal-title":"J Nutr Biochem"},{"key":"7560_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.pnpbp.2017.09.015","volume":"81","author":"C Roomruangwong","year":"2018","unstructured":"Roomruangwong C, Anderson G, Berk M, Stoyanov D, Carvalho AF, Maes M. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:262\u201374.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7560_CR55","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/eip.12775","volume":"13","author":"OD Robertson","year":"2019","unstructured":"Robertson OD, Coronado NG, Sethi R, Berk M, Dodd S. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Interv Psychiatry. 2019;13:1032\u201349.","journal-title":"Early Interv Psychiatry"},{"key":"7560_CR56","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/ijms24021022","volume":"24","author":"N Treder","year":"2023","unstructured":"Treder N, Mart\u00ednez-Pinte\u00f1o A, Rodr\u00edguez N, Arbelo N, Madero S, G\u00f3mez M, et al. The effect of clozapine and novel glutamate modulator JNJ-46356479 on nitrosative stress in a postnatal murine ketamine model of schizophrenia. Int J Mol Sci. 2023;24:1022.","journal-title":"Int J Mol Sci"},{"key":"7560_CR57","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/antiox11071374","volume":"11","author":"EE Tsermpini","year":"2022","unstructured":"Tsermpini EE, Plemenita\u0161 Ilje\u0161 A, Dol\u017ean V. Alcohol-induced oxidative stress and the role of antioxidants in alcohol use disorder: a systematic review. Antioxid (Basel). 2022;11:1374.","journal-title":"Antioxid (Basel)"},{"key":"7560_CR58","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/brainsci10100742","volume":"10","author":"S Madireddy","year":"2020","unstructured":"Madireddy S, Madireddy S. Regulation of reactive oxygen species-mediated damage in the pathogenesis of schizophrenia. Brain Sci. 2020;10:742.","journal-title":"Brain Sci"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07560-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:05:07Z","timestamp":1763409907000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07560-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7560"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07560-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6906160\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Committee of Lianyungang Fourth People\u2019s Hospital (approval no. 2019LSYYXLL-P06) and conducted in accordance with the ethical principles for medical research involving human subjects described in the Declaration of Helsinki. Prior to inclusion in this study, informed consent was obtained from all participants and\/or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1092"}}